Correlation Between IBio, Common and Vaxart

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IBio, Common and Vaxart at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IBio, Common and Vaxart into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iBio, Common Stock and Vaxart Inc, you can compare the effects of market volatilities on IBio, Common and Vaxart and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IBio, Common with a short position of Vaxart. Check out your portfolio center. Please also check ongoing floating volatility patterns of IBio, Common and Vaxart.

Diversification Opportunities for IBio, Common and Vaxart

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between IBio, and Vaxart is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding iBio, Common Stock and Vaxart Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxart Inc and IBio, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iBio, Common Stock are associated (or correlated) with Vaxart. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxart Inc has no effect on the direction of IBio, Common i.e., IBio, Common and Vaxart go up and down completely randomly.

Pair Corralation between IBio, Common and Vaxart

Given the investment horizon of 90 days iBio, Common Stock is expected to generate 1.04 times more return on investment than Vaxart. However, IBio, Common is 1.04 times more volatile than Vaxart Inc. It trades about 0.17 of its potential returns per unit of risk. Vaxart Inc is currently generating about -0.06 per unit of risk. If you would invest  238.00  in iBio, Common Stock on December 28, 2024 and sell it today you would earn a total of  193.00  from holding iBio, Common Stock or generate 81.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

iBio, Common Stock  vs.  Vaxart Inc

 Performance 
       Timeline  
iBio, Common Stock 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in iBio, Common Stock are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, IBio, Common displayed solid returns over the last few months and may actually be approaching a breakup point.
Vaxart Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vaxart Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

IBio, Common and Vaxart Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IBio, Common and Vaxart

The main advantage of trading using opposite IBio, Common and Vaxart positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IBio, Common position performs unexpectedly, Vaxart can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxart will offset losses from the drop in Vaxart's long position.
The idea behind iBio, Common Stock and Vaxart Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets